AVAXIM

This brand name is authorized in Brazil, Canada, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong, Ireland, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, South Africa

Active ingredients

The drug AVAXIM contains one active pharmaceutical ingredient (API):

1 Hepatitis A virus, purified inactivated UNII G54MT8V18G - HEPATITIS A VIRUS

Inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminum hydroxyphosphate sulphate. Read about Hepatitis A, inactivated vaccine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AVAXIM Suspension for injection in a prefilled syringe	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BC02	Hepatitis A, inactivated, whole virus	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BC Hepatitis vaccines
Discover more medicines within J07BC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 576720020055817, 576720020055917, 576720020056017
Country: CA	Health Products and Food Branch	Identifier(s): 02237792
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 21.784-1-05-05, 25.633-04-04
Country: EE	Ravimiamet	Identifier(s): 1024300
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 483443
Country: FR	Base de données publique des médicaments	Identifier(s): 62756524, 63777215
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 30043, 30049
Country: HK	Department of Health Drug Office	Identifier(s): 55399, 56399
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008337, 1035094, 1035095, 1035096
Country: MT	Medicines Authority	Identifier(s): AA1438/00201, AA1438/00202, AA770/17001
Country: NL	Z-Index G-Standaard	Identifier(s): 14090287
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 62030
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8769
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100195673
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W13439001, W13439002, W13439003, W13439004, W58081001, W58081002, W58081003, W58081004, W58081005, W58081006
Country: SG	Health Sciences Authority	Identifier(s): 10611P, 13830P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 12063101
Country: ZA	Health Products Regulatory Authority	Identifier(s): 30/30.1/0244, 35/30.1/0401